carb-x-interior-header

US and UK partnership to fund the fight against superbugs

March 31, 2017
Medical Communications, Research and Development CARB-X, Wellcome Trust

The cross-Atlantic partnership CARB-X, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, has announced that it would be funding 11 biotech companies …

giles_platford

Takeda names new President of Europe and Canada Business Unit

March 31, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment

Takeda has named Giles Platford as its new President of Europe and Canada (EUCAN) Business Unit as of 1 April, …

paul-catchpole

Insider Interview: ABPI’s Paul Catchpole discusses NICE’s new fast-track appraisal system

March 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Insider Interview, NICE, Paul Catchpole, fast track

Paul Catchpole, Value and Access Director at the Association of the British Pharmaceutical Industry (ABPI), gives his thoughts on the …

fda2outsideweb

Trump’s FDA pick vows to sever past pharma ties to avoid partisanship

March 30, 2017
Medical Communications, Sales and Marketing FDA, Scott Gottlieb, Trump

After much speculation, Donald Trump recently announced his top pick for Commissioner of the FDA as Dr Scott Gottlieb. Gottlieb …

Mylan’s generic of best-selling GSK drug delayed by FDA

March 30, 2017
Sales and Marketing Advair, GSK, Mylan

Mylan’s plan to bring its generic competitor to GSK’s best-selling respiratory drug, Advair, has hit a major snag after it …

roche_close

First treatment for form of MS approved by FDA

March 30, 2017
Sales and Marketing Biogen, Genentech, MS, Roche

In big news for sufferers of MS and the company that developed the drug, Roche subsidiary Genetech, the FDA has …

novartis_outside_1

Novartis investigational CAR-T therapy gets FDA priority review

March 30, 2017
Sales and Marketing CTL019, FDA, Novartis, leukaemia

Novartis’ investigational chimeric antigen receptor T cell (CAR-T) therapy CTL019 (tisagenlecleucel-T) has been awarded has been awarded priority review by …

nhs_bands

Women are 77% of NHS workforce but occupy only 41% board positions

March 29, 2017
Medical Communications NHS

A new report, entitled Women on NHS board: 50:50 by 2020, found that women occupied only 41% of board positions …

pharmafocus_april_front_cover

The April 2017 edition of Pharmafocus is available to read online now!

March 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Pharmafocus new issue

From industry reaction to NICE’s new regulatory guidelines to the rising threat of counterfeit medicine, you can read all the …

evatar

Replica reproductive tract could aid drug trials

March 29, 2017
Research and Development Woodruff lab

If most people were asked whether they had heard of a scandal in the pharmaceutical industry, the drug that would …

diabetes-777001_960_720

New drug therapy ‘reverses’ diabetes in mice

March 29, 2017
Research and Development diabetes

A team of researchers at the University of California, San Diego (UCSD) have developed a drug therapy which has shown …

sanofi_regeneron

Breakthrough eczema drug given FDA approval

March 29, 2017
Research and Development, Sales and Marketing Dupixent, Regeneron, Sanofi

Regeneron and Sanofi have received approval for its eczema treatment, Dupixent, by the FDA. The treatment will be the first …

nhs_bands

Cuts to prescriptions aims to save £128 million annually

March 28, 2017
Medical Communications, Research and Development NHS England, prescription

NHS England has identified 10 items that it believes can cut £128 million from its yearly bill. The 10 items …

ludwig_hantson_small

Alexion leadership uncertainty ends as ex-Baxalta CEO steps in

March 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, CEO

Alexion had been left in leadership limbo for the beginning of the year, as former CEO and CFO left under …

Renowned scientist Owen N. Witte joins Kite Pharma Board of Directors

March 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Kite Pharma has revealed the addition of celebrated bioscientist and researcher Dr Owen N. Witte to its Board of Directors, …

mylan

Mylan set to close Meda US manufacturing facility

March 28, 2017
Manufacturing and Production Meda, Mylan

Mylan continues to cut away Meda’s US operations to “reduce redundancy” – the latest sees Mylan closing an Illinois-based facility, …

valeant_web

Former Valeant CEO Michael Pearson sues over $30m unpaid shares

March 28, 2017
Manufacturing and Production, Sales and Marketing Michael Pearson, Valeant

Ex-Valeant CEO Michael Pearson is suing his former company over its failure to deliver three million shares he claims he …

ema_building_face_web

EMA recommends suspension of 331 drugs over testing concerns

March 28, 2017
Manufacturing and Production, Sales and Marketing Aurobindo, Micro Therapeutic Research Labs, Novartis, Sandoz

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has called for the suspension of 331 drugs due to …

computer_and_doctor

45% of healthcare professionals not disclosing payments from industry

March 28, 2017
Manufacturing and Production, Medical Communications ABPI, disclosure, disclosure uk

The research organisation ABPI, alongside RAND Europe, has released a ‘snapshot’ of data, from its Disclosure UK database, from January …

Butterworth Laboratories secures additional facility

March 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Leading UK contract analytical chemistry provider, Butterworth Laboratories Ltd, is delighted to announce it has secured an additional facility in …

The Gateway to Local Adoption Series

Latest content